HeartFlow

Regulatory Specialist

United States

HeartFlow Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Devices, Healthcare TechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree and 1-3 years of experience in Regulatory Affairs, demonstrating a strong understanding of regulatory requirements and the ability to resolve a wide range of issues while maintaining compliance to regulations and standards. Familiarity with global regulatory requirements and experience with US FDA submissions is desired.

Responsibilities

The Regulatory Affairs Specialist will support frequent minor software releases by performing change assessments, collaborate with cross-functional teams to drive regulatory project management activities, manage timely completion of new product registrations and maintain global regulatory approvals to market software devices, collaborate with external partners including regulatory agencies, authorized representatives, importers and distributors, gain experience with US FDA submissions, provide input to the risk management process to ensure risks are identified and updated during the product life-cycle, conduct regulatory surveillance and communicate changes in regulations, standards, and guidances, and support Quality System management as needed. They will also perform change assessments and work in a fast-paced, adaptive environment as a self-starter and team player.

Skills

Regulatory Affairs
Medical Device Regulations
EU MDR
US FDA submissions
Regulatory Documentation
Risk Management
Regulatory Surveillance
Cross-functional Collaboration

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Key Metrics

Redwood City, CaliforniaHeadquarters
2010Year Founded
$858.5MTotal Funding
SERIES_FCompany Stage
HealthcareIndustries
501-1,000Employees

Benefits

Remote Work Options
Stock Options
401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.
Algorithmic bias in AI models could lead to inaccurate diagnoses.
Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.
HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.
HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.
The global non-invasive cardiac imaging market is projected to grow significantly.
HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI